July 15, 2025

TILs: What Are They and How Are They Used in Cancer Treatment?

Tumor-infiltrating lymphocyte, or TIL, therapy uses a patient’s own immune system T cells to fight cancer.

Dana-Farber

July 29, 2025

U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nation’s Best for 2025-2026

Recognition marks a quarter of a century of excellence

Dana-Farber

July 01, 2025

Tracing a Career of Unrelenting Discovery

Dr. Ben Ebert's Legacy of Collaborative Research Fuels Innovation at Dana-Farber

Dana-Farber

August 05, 2025

Polatuzumab Vedotin–Based Regimen Improves Overall Survival in Refractory DLBCL

Combining the CD79b-directed antibody-drug conjugate polatuzumab vedotin-piiq with rituximab, gemcitabine, and oxaliplatin (R-GemOx) significantly improved survival outcomes in patients with transplan...

The ASCO Post

July 26, 2025

With New Treatment Strategies, a Cure for Multiple Myeloma Is Now Possible

Long considered one of the most deadly and incurable cancers, multiple myeloma is now being viewed by more and more oncologists as an eminently treatable disease based on exciting new immunotherapies, including CAR T-cell therapy and bispecific antibodies.

Mount Sinai New York

July 29, 2025

Elevating Sarcoma Care: Multidisciplinary Collaboration and Innovation in Rare Cancer Treatment Page Summary

Sarcomas remain one of the most diverse and challenging cancer types to diagnose and treat. Baptist Health Cancer Care continues to advance care through coordinated expertise, early detection efforts, and emerging research opportunities.

Baptist Health South Florida

July 29, 2025

Evidence of Potential Cure With Single CAR T-Cell Infusion for Some Patients With Multiple Myeloma

In long-term results from the CARTITUDE-1 trial, investigators had found that the autologous cellular immunotherapy ciltacabtagene autoleucel was potentially curative for one-third of patients with he...

The ASCO Post

July 24, 2025

Updates in Systemic Light-Chain Amyloidosis

Systemic amyloid light-chain (AL) amyloidosis is characterized by the deposition of immunoglobulin light chains, produced by clonal CD38-positive plasma cells, as insoluble amyloid fibrils in vital or...

The ASCO Post

July 08, 2025

Teen with Rare Sarcoma Enjoys Stellar Response on Clinical Trial

Like many teenagers, Isabella (Bella) Snow Fraser, 15, enjoys immersing herself in action role-play games online.

Dana-Farber